A web tool for designing and conducting phase I trials using the continual reassessment method

by Nolan A. Wages, Gina R. Petroni
Published 2018-02-01

Efficient dose-finding for drug combination studies involving a shift in study populations

by Nolan A. Wages, Trish A. Millard, Patrick M. Dillon, Christiana M. Brenin, Gina R. Petroni
Published 2020-03-01

Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas

by Charles A. Fox, Lisa M. Sapinoso, Hong Zhang, Wanghai Zhang, Howard L. McLeod, Gina R. Petroni, Tarun Mullick, Christopher A. Moskaluk, Henry F. Frierson, Garret M. Hampton, Steven M. Powell
Published 2005-04-01

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist

by Craig L Slingluff, Gina R Petroni, Walter C Olson, Kimberly A Chianese-bullock, Donna Deacon, Mark Smolkin, William W Grosh, Max O Meneveau, Kevin T Lynch, Elise P Salerno, Elizabeth Woodson, James W Patterson
Published 2021-05-01

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

by Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, Nadejda V. Galeassi, Donna H. Deacon, Elizabeth M. Gaughan, Craig L. Slingluff
Published 2019-06-01

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

by Patrick M. Dillon, Gina R. Petroni, Mark E. Smolkin, David R. Brenin, Kimberly A. Chianese-Bullock, Kelly T. Smith, Walter C. Olson, Ibrahim S. Fanous, Carmel J. Nail, Christiana M. Brenin, Emily H. Hall, Craig L. Slingluff
Published 2017-11-01